The pharmaceutical corporation leads a $10m funding round for Daktari Diagnostics, which develops HIV testing equipment for use in developing countries.
US-based diagnostic testing company Daktari Diagnostics raised $10m in funding last Friday in a round led by pharmaceutical conglomerate Merck’s Global Health Innnovation Fund.
Also participating in the round were venture capital firm Norwich Ventures and the Partners Innovation Fund, an investment unit belonging to Brigham and Women’s Hospital, the teaching hospital attached to Harvard University.
According to finance database Crunchbase, Daktari has now raised a total of $15.8m from a pool of investors also including angel and seed…
